AgomAb Therapeutics NV

AGMBNASDAQHealthcareBiotechnology

$8.28- (-)

As of Oct 16, 2026 close

Market cap: $339.56M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $7.97$17.82
Volume (live): -
Avg. volume (3M): 153.49K

AgomAb Therapeutics NV (AGMB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for AgomAb Therapeutics NV stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy

Based on 7 unique analysts

(9 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$35.00

+322.71% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest AGMB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 14, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$60.00
Oct 12, 2026	Judah Frommer	Morgan Stanley	Maintains	Buy	$28.00
Oct 5, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$60.00
Oct 5, 2026	Judah Frommer	Morgan Stanley	Reiterates	Buy	$28.00
Oct 2, 2026	Unknown Analyst	Leerink Partners	Reiterates	Buy	$36.00
Oct 1, 2026	Patrick Trucchio	HC Wainwright	Reiterates	Buy	$35.00
Sep 15, 2026	Anupam Rama	JP Morgan	Maintains	Buy	-
Aug 19, 2026	Yanni Souroutzidis	Cantor Fitzgerald	Initiates	Buy	$13.00 → $17.00 +4.00 (+30.8%)
Jul 23, 2026	William Wood	B Riley	Initiates	Buy	$34.00

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$60.00

Oct 14

Judah Frommer

Morgan Stanley

BuyMaintains

$28.00

Oct 12

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$60.00

Oct 5

Judah Frommer

Morgan Stanley

BuyReiterates

$28.00

Oct 5

Unknown Analyst

Leerink Partners

BuyReiterates

$36.00

Oct 2

Patrick Trucchio

HC Wainwright

BuyReiterates

$35.00

Oct 1

Anupam Rama

JP Morgan

BuyMaintains

Sep 15

Yanni Souroutzidis

Cantor Fitzgerald

BuyInitiates

$13.00 → $17.00

Aug 19

William Wood

B Riley

BuyInitiates

$34.00

Jul 23

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 14, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for AGMB?

The analyst consensus rating for AGMB is Buy, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for AGMB?

The average 12-month price target for AGMB is $35.00, representing an upside of 322.7% from the Oct 16, 2026 close of $8.28.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.